NextCure Inc (NAS:NXTC)
$ 1.17 0 (0%) Market Cap: 32.77 Mil Enterprise Value: -37.15 Mil PE Ratio: 0 PB Ratio: 0.43 GF Score: 40/100

NextCure Inc at Bank of America Biotech SMID Cap Conference Transcript

Dec 08, 2022 / 08:20PM GMT
Release Date Price: $1.41 (-0.70%)
Operator

Ladies and gentleman, the program is about to begin. Reminder that you can submit questions at any time via the ask questions tab on the webcast page. At this time, it is my pleasure to turn the program over to your host, Alec Stranahan.

Alec Warren Stranahan
BofA Securities, Research Division - Associate

Okay. Hello, everyone. Welcome to the end of day 2 of the 2022 Bank of America Healthcare Conference, and thanks for joining the session with next cure. My name is Alex Stranahan. I'm Vice President and Senior Biotic analysts covering NextCure here at BofA. And I'm pleased to be joined by Michael Richman. President and Chief Executive Officer of NextCure. Michael, thanks for joining.

Michael S. Richman
NextCure, Inc. - Co-Founder, CEO, President & Director

Thank you, Alec. Great to be here, and thanks for including us in this year's conference.

Alec Warren Stranahan
BofA Securities, Research Division - Associate

Great. Great. So I believe I believe Michael is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot